Cart
sales@molnova.com
TP0586532
CAS No. 2427584-96-9
TP0586532 ( —— )
Catalog No. M28602 CAS No. 2427584-96-9
TP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 284 | Get Quote |
|
| 10MG | 448 | Get Quote |
|
| 25MG | 860 | Get Quote |
|
| 50MG | 1341 | Get Quote |
|
| 100MG | 2124 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTP0586532
-
NoteResearch use only, not for human use.
-
Brief DescriptionTP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.
-
DescriptionTP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.(In Vitro):TP0586532 is an inhibitor of UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) with an IC50 of 0.101 μM.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCB1R
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2427584-96-9
-
Formula Weight460.5
-
Molecular FormulaC26H28N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)CCCN1C[C@@]2([H])[C@H](C#CC3=CC=C(C4=CC(CN5C=CN=C5[C@@H](O)C)=NO4)C=C3)[C@@]2([H])C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andreas W Herling, et al. CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats. Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E826-32.
molnova catalog
related products
-
Benzo[a]pyrene
Benzo[a]pyrene shows lung carcinogenicity in mice in a dose-dependent manner.
-
N-Methylflindersine
N-Methylflindersine shows strong toxicity towards brine shrimp larvae, with an LD(50) value of 1.39 microg/ml.
-
SRI-37330
SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
